Moxifloxacin Penetration in Bronchial Secretions of Mechanically Ventilated Patients with Pneumonia
AUTOR(ES)
Leone, Marc
FONTE
American Society for Microbiology
RESUMO
The pharmacokinetics of moxifloxacin was studied in 17 mechanically ventilated patients with pneumonia. Patients were given 400 mg of moxifloxacin intravenously. Blood samples and bronchial secretions were taken on days 1 and 4. A dose of 400 mg of moxifloxacin allows one to achieve efficient concentrations in bronchial secretions and plasma.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=321546Documentos Relacionados
- Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.
- Clinical and microbiological characterization of pneumonia in mechanically ventilated patients
- Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
- Prognosis of mechanically ventilated patients.
- Penetration of pefloxacin into bronchial secretions.
